ACR Introduces New Clinical Topics in Latest Appropriateness Criteria Update
New guidance includes pediatric imaging, sarcopenia evaluation, and other emerging clinical needs.
New guidance includes pediatric imaging, sarcopenia evaluation, and other emerging clinical needs.
Robert Dannals, PhD, and Martin Pomper, MD, PhD, named 2026 Faces of American Innovation, discuss the scientific and radiochemistry work behind the prostate cancer imaging agent PYLARIFY.
The FDA clearance paves the way for the official launch of an AI-powered MRI enhancement suite designed to improve imaging efficiency and quality.
After a major study suggests risk-based breast cancer screening could be a safe alternative to annual mammography, the American College of Radiology says the data do not justify changes to existing screening recommendations.